Evaluation of the rasayana effect of Amrit Bhallataka and Ashwagandhadi lehya in akaalaja jara (Premature ageing)

Phase 2

Not yet recruiting

• Conditions: Unspecified protein-calorie malnutrition. Ayurveda Condition: VARDHAKYAM,

• Registration Number: CTRI/2022/12/048302
• Lead Sponsor: National Institute of Ayurveda

Brief Summary

60 Patients showing more than 3 sign of  premature ageing will be selected and would be randomly divided  in two groups. In first group Amrit Bhallatak  and in second group, Ashawagandhadi lahya  will be given for 48 days. before and after treatment assessment for premature ageing sign, QOL questioner and laboratory investigation - SOD, Hb, LFT would be done.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-12-16
• Study Start: 2022-12-27

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1.having 3 symptoms of premature ageing 2.Patients willing to give written informed consent.

Exclusion Criteria

• Patients with any type of psychiatric disorder, Alzheimer’s disease, parkinsonism etc.
• 2.Patients with any major diseases like carcinoma, heart disease, DM, hyperhypothyrodism, hypertension etc.
•  Patients giving present history of addiction to drug, tobacco or alcohol.
•  Pitta prakriti person will be excluded on the basis of CCRAS short prakriti performa  Pregnant and lactating females.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in score of Akaalaj jara lakshana	7 weeks

Secondary Outcome Measures

Name	Time	Method
change in WHO-Quality of Life Bref	Oxidative stress- SOD level

Trial Locations

Locations (1)

National Institute of Ayurveda Hospital,Jaipur; 🇮🇳 Jaipur, RAJASTHAN, India

National Institute of Ayurveda Hospital,Jaipur

🇮🇳Jaipur, RAJASTHAN, India

Dr Jyoti Rani

Principal investigator

7495098825

jyotisurya2014@gmail.com